Dyne pursues rare disease breakthroughs while Vertex leverages blockbuster profits for pipeline expansion, how do their risk ...

Mankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This ...

Huons Group is accelerating its focus on pharmaceuticals and bio-business through subsidiary restructuring and mergers and acquisitions (M&A). The company is overhauling its existing structure ...

Industries from semiconductors to fiber-optic cables stand to benefit from space research and manufacturing, but experts told CNBC that medicine could see the most immediate disruption. A flurry of ...

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their financials and risk profiles stack up?

By Maggie Fick BRUSSELS, June 23 (Reuters) - China has pulled ahead of Europe in pharmaceutical innovation and drug ...

Study designed to evaluate performance and formulation stability of proprietary nose-to-brain delivery systemSARASOTA, FLA., June 29, 2026 ...

King of Prussia, Pennsylvania--(Newsfile Corp. - December 23, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its ...

We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Ascentage Pharma Group Internat ...

Mankind Pharma collaborates with Denovo Sciences for AI-driven drug discovery, aiming to enhance candidate quality and reduce ...

A clinical-stage innovator faces off against an established biotech powerhouse, each with distinct financials and risk profiles shaping their 2026 outlook.